Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Athira Pharma (formerly M3 Biotechnology), the WSU spinout founded to commercialize Dihexa-derivative compounds, paid approximately $4 million in a False Claims Act settlement in January 2025 after a whistleblower exposed concealment of the research misconduct from federal grant agencies, and approximately $10 million in a separate class-action settlement to investors
Tell me in the comments if either of these scenarios sound familiar
Over time, its also been studied for its potential effects on: Stress regulation Cortisol levels Pain perception Withdrawal symptoms That last point is whats driving interest in addiction and recovery spaces today
The human brain somatostatin interactome: SST binds selectively to P-type family ATPases
US$ 27.67
US$ 26.73
US$ 21.11
US$ 21.39
US$ 27.08
US$ 22.13
US$ 28.10
US$ 24.52
